ID   UKAi004-A
AC   CVCL_A5IU
SY   P4_wt4; Patient 1 control 1
DR   BioSamples; SAMEA8172007
DR   hPSCreg; UKAi004-A
DR   Wikidata; Q107117221
RX   PubMed=33512435;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation.
CC   Sequence variation: Mutation; HGNC; 76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; 7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Cys973Alafs*34 (c.2917delT); Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5IV ! UKAi004-B
OI   CVCL_A5IW ! UKAi004-C
OI   CVCL_A5IX ! UKAi004-D
OI   CVCL_A5IY ! UKAi004-E
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
RX   PubMed=33512435; DOI=10.1182/blood.2019004509;
RA   Szymanski de Toledo M.A., Gatz M., Sontag S., Gleixner K.V.,
RA   Eisenwort G., Feldberg K., Hamouda A.E.I., Kluge F., Guareschi R.,
RA   Rossetti G., Sechi A.S., Dufva O.M.J., Mustjoki S.M., Maurer A.,
RA   Schuler H.M., Goetzke R., Braunschweig T., Kaiser A., Panse J.,
RA   Jawhar M., Reiter A., Hilberg F., Ettmayer P., Wagner W., Koschmieder S.,
RA   Brummendorf T.H., Valent P., Chatain N., Zenke M.;
RT   "Nintedanib targets KIT D816V neoplastic cells derived from induced
RT   pluripotent stem cells of systemic mastocytosis.";
RL   Blood 137:2070-2084(2021).
//